Dualit wins UK dispute Nespresso-compatible coffee capsules

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Dualit wins UK dispute Nespresso-compatible coffee capsules

The High Court in London has ruled that Dualit, a UK company that makes coffee machines and capsules, is able to sell Dualit NX capsules that are compatible with Nestle’s Nespresso machines

Nestec, which owns the Nespresso brand, accused Dualit of infringing its EP (UK) 2 103 236 patent by supplying coffee capsules that consumers can use in the Swiss company’s Nespresso machines. Dualit denied infringing the patent, which it said was invalid on the grounds of prior use by Nestec.

On Monday Mr Justice Arnold ruled that the patent was invalid and that, even if it was valid, Dualit had not infringed it.

Coffee capsule patent

Leslie Gort-Barten, managing director of Dualit and a defendant in the case, welcomed the ruling, describing it as victory for consumers and a “win-win” for retailers: “Not only will it grow retailers’ profits since they have greater access to the lucrative replacement capsule sector but we see it will boost the overall popularity and sales of coffee machines – the UK coffee culture is currently worth £4 billion annually,” he said.

Arnold criticised the parties for litigating a range of issues, rather than “concentration upon the essentials”. He also rejected Nestec’s arguments that the facts that its machines were fitted with “tamper proof” screws showed that the machines were not intended to be disassembled.

“In my judgment it makes no difference that the screws were ‘tamper proof’”, said Arnold. “The screws were only ‘tamper proof’ in the sense that slightly more specialised, but nevertheless widely available, equipment was required to undo them than ordinary screws. It follows that a skilled person in the position of the consumers could readily disassemble one of the machines. In the absence of any obligation of confidentiality, he would have been free in law and equity to disassemble the machine and to use the information gained thereby. Thus the information was made available to the public.”

Litigation over IP rights for coffee machines and capsules is being conducted between various companies in disputes in many European countries.

Simon Thorley QC and Benet Brandreth, instructed by Bird & Bird, advised Nestec, Nestlé Nespresso and Nespresso UK. Mark Vanhegan QC and Anna Edwards-Stuart (instructed by Jensen & Son) advised Dualit. 

In a statement, Daniel Weston, general counsel for Nestlé Nespresso, said the company was disappointed with the ruling and considering its options: “We believe the decision is inconsistent with the ruling by the European Patent Office in April 2012, confirming the validity of a key patent for the Nespresso system."

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article